Home/Filings/4/0001209191-22-044459
4//SEC Filing

Funtleyder Leslie D. 4

Accession 0001209191-22-044459

CIK 0001697532other

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 8:35 PM ET

Size

21.5 KB

Accession

0001209191-22-044459

Insider Transaction Report

Form 4
Period: 2022-08-02
Funtleyder Leslie D.
DirectorChief Financial Officer
Transactions
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-02+16,50016,500 total
    Exercise: $1.05Exp: 2031-06-02Common Stock (16,500 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-0216,5000 total
    Exercise: $1.22Exp: 2032-06-02Common Stock (16,500 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-02+20,46020,460 total
    Exercise: $1.05Exp: 2029-05-12Common Stock (20,460 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-02+16,50016,500 total
    Exercise: $1.05Exp: 2032-06-02Common Stock (16,500 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-0216,5000 total
    Exercise: $19.70Exp: 2031-06-02Common Stock (16,500 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-0210,2300 total
    Exercise: $44.02Exp: 2030-06-03Common Stock (10,230 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-02+10,23010,230 total
    Exercise: $1.05Exp: 2030-06-03Common Stock (10,230 underlying)
  • Disposition to Issuer

    Employee Stock Option (Right to Buy)

    2022-08-0220,4600 total
    Exercise: $10.00Exp: 2029-05-12Common Stock (20,460 underlying)
Footnotes (3)
  • [F1]The transaction reported herein reflects a one-time stock option repricing that became effective on August 2, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.
  • [F2]Reflects an initial grant of 16,500 Options granted on June 3, 2022 that vests as follows: One-twelfth (1/12th) of the shares subject to the Option shall vest on July 2, 2022 and each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
  • [F3]These Options are fully vested.

Issuer

Applied Therapeutics Inc.

CIK 0001697532

Entity typeother

Related Parties

1
  • filerCIK 0001775394

Filing Metadata

Form type
4
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 8:35 PM ET
Size
21.5 KB